Seeing Is Believing
Currently out of the existing stock ratings of Robert Jones, 27 are a HOLD (36.49%), 6 are a SELL (8.11%), 41 are a BUY (55.41%).
Analyst Robert Jones works with a stock forecast success ratio of 80% fulfilled within 352.79 days on average. Previously, Robert Jones worked at BMO.
Robert Jones’s has documented 175 price targets and ratings displayed on 24 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ALGN, Align Technology at 27-Oct-2023.
Analyst best performing recommendations are on ANTM (ANTHEM).
The best stock recommendation documented was for XRAY (DENTSPLY SIRONA) at 4/7/2020. The price target of $40 was fulfilled within 2 days with a profit of $2.81 (7.56%) receiving and performance score of 37.78.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
215
$40.04 (22.89%)
187
8 months 17 days ago
14/15 (93.33%)
$28.91 (15.54%)
667
Hold
190
$15.04 (8.60%)
176
8 months 21 days ago
7/7 (100%)
$-0.86 (-0.45%)
477
Buy
220
$45.04 (25.74%)
213
8 months 21 days ago
11/17 (64.71%)
$29.14 (15.27%)
326
Buy
215
$40.04 (22.89%)
200
8 months 21 days ago
6/8 (75%)
$24.14 (12.65%)
220
Buy
225
$50.04 (28.60%)
184
8 months 23 days ago
11/12 (91.67%)
$36.39 (19.29%)
557
What Year was the first public recommendation made by Robert Jones?